Akebia Therapeutics
AKBA
#8233
Rank
C$0.37 B
Marketcap
C$1.39
Share price
12.84%
Change (1 day)
-65.82%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: C$0.37 Billion

As of May 2026 Akebia Therapeutics has a market cap of C$0.37 Billion. This makes Akebia Therapeutics the world's 8233th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.37 B-38.27%
2025C$0.60 B-1.19%
2024C$0.61 B97.04%
2023C$0.30 B115.11%
2022C$0.14 B-71.42%
2021C$0.50 B-2.35%
2020C$0.51 B-48.62%
2019C$1.00 B14.06%
2018C$0.88 B-0.36%
2017C$0.88 B64.83%
2016C$0.53 B-2.44%
2015C$0.54 B99.71%
2014C$0.27 B

End of Day market cap according to different sources

On May 19th, 2026 the market cap of Akebia Therapeutics was reported to be:

C$0.33 Billion
by Nasdaq info icon info icon
C$0.33 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$758.71 B 203,643.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$394.55 B 105,853.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
C$246.08 B 65,983.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$3.22 B 766.53%๐Ÿ‡บ๐Ÿ‡ธ USA